The generic drug industry has warned that US tariffs on pharmaceuticals risk causing shortages of medicines including cancer treatments, and that manufacturers might stop making products that become unprofitable as a result.
仿製藥行業警告稱，美國對藥品徵收關稅可能導致包括癌症治療在內的藥品短缺，製造商可能會停止生產因此變得無利可圖的產品。
您已閱讀5%（282字），剩餘95%（5569字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。